The CSF3R gene helps bone marrow cells respond to a natural growth signal that tells the body to make and release neutrophils, a type of white blood cell that fights infection. If this gene does not work properly, the body may make too few infection fighting cells or send the wrong growth signals, which can contribute to very low neutrophil counts from birth or certain blood cancers, including some leukemias. Many variants in this gene have little effect, while a smaller number can change how blood cells grow and mature.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes contain the information needed to produce proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. If you want to explore this subject more deeply, you can learn more in the LearnHub.
Overview
CSF3RGene function
What if the gene works
The CSF3R gene helps your bone marrow make and mature neutrophils, a type of white blood cell. It lets these cells respond to a growth signal that supports infection fighting and healthy blood cell balance.
Risk
What if the gene does not work
Variants in the CSF3R gene can disrupt white blood cell growth. Depending on the variant, this may cause low neutrophil counts with repeated infections, or blood conditions marked by too many neutrophils; effects can range from milder to more severe.
Treatment
What does that mean for your treatment
No CSF3R-specific treatment or management approach is currently established for a pathogenic or loss-of-function variant in the CSF3R gene. In myeloid blood cancers, the CSF3R gene is being studied as a treatment guide, especially for targeted drugs such as ruxolitinib.
Conditions associated with CSF3R
Gene function
What if the gene works
In your bone marrow, the CSF3R gene helps your body keep a steady supply of neutrophils, a white blood cell that fights germs. Its protein sits on the cell surface and relays messages from G-CSF, a natural growth signal. This is central to how the CSF3R gene helps make neutrophils and support daily immune defense.
The CSF3R gene makes a receptor that sits on the surface of certain bone marrow cells and neutrophils. When G-CSF attaches, the receptor carries that message into the cell so it can respond.
These signals help early bone marrow cells grow and divide along the neutrophil pathway. This supports a steady, controlled supply of new white blood cells for everyday immune needs.
The receptor helps guide immature cells as they develop into mature neutrophils. It supports the timing of this process so cells are ready to move from the bone marrow into the bloodstream.
In mature neutrophils, messages through this receptor help cells stay available and active during routine immune defense. This supports cell survival and helps neutrophils move toward signals from inflamed tissue.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
CSF3R gene variants can make the receptor signal too much, too little, or for too long. The way CSF3R gene variants affect receptor signaling depends on the change: some near the cell surface switch signaling on without the usual trigger, while truncating variants remove the tail that helps turn signaling off. Other variants reduce receptor production or cell surface response. These effects range from milder to more disruptive and may influence whether blood conditions appear earlier or are more pronounced.
How variants are linked to conditions
Certain inherited variants in the CSF3R gene can cause severe congenital neutropenia, a condition with very low neutrophil counts and repeated infections. Acquired CSF3R variants that arise in blood cells are also strongly linked to chronic neutrophilic leukemia and may support the diagnosis of some closely related myeloid blood cancers. The meaning of a CSF3R variant depends on the exact change and on whether it is inherited or acquired.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, however, a single well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CSF3R gene itself. Risk depends mostly on the exact gene change and whether it is inherited or acquired during life, so personal concerns are best discussed with a doctor or genetic counselor.
Inheritance of CSF3R variants
For people learning how CSF3R gene variants are inherited, the main disease linked to inherited CSF3R changes follows an autosomal dominant pattern. This means one altered copy of the CSF3R gene can be enough to cause the condition. A parent carrying the variant has a 50% chance of passing it on in each pregnancy. Sons and daughters can inherit it equally because the CSF3R gene is on chromosome 1.
What does my CSF3R result mean for my family?
For the inherited CSF3R condition that is best established, changes in this gene can run in families in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same change. In practical terms, a family result can matter beyond one person, because other relatives may have similar blood count findings or related health issues even if they feel well. The exact family impact depends on whether the CSF3R change is an inherited finding or a change found only in blood cells.
Genetic information
Genetic testing
How you find out about variants
CSF3R genetic testing usually uses a blood, saliva, or bone marrow sample. A lab reads the DNA in the CSF3R gene to look for variants, often as part of a larger blood cancer panel, and the results can show whether a CSF3R variant is present.
When should I consider getting a genetic test?
If blood tests show a long-lasting, unexplained rise in neutrophils, CSF3R testing may be considered because certain changes can help confirm some rare blood cancers. It may also come up when doctors are evaluating inherited problems with neutrophils or a family pattern of unusual white blood cell counts.
A genetic result is only one part of your health story
A genetic finding can provide helpful insight, but how much it reveals depends on the condition and the type of variant involved. How the body works over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body absorbs, breaks down, transports, or responds to drugs in different ways. These differences are common and can influence both how well a medicine helps and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. By looking at links between genes and medications, it helps explain why the same treatment may work differently in different people. For many drugs, genetic factors influence how strongly a medicine works or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More on this topic is available in the LearnHub.
Drugs influenced by the CSF3R gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general concerns about medicines or side effects are best discussed with your doctor. In some blood cancers, CSF3R changes can help specialists think about treatment options, but this is a cancer care issue rather than a routine prescribing guide.
History
CSF3R entered medical genetics through blood research, as scientists worked to understand how the body controls infection-fighting white blood cells. In recent decades, awareness of this gene’s role has grown. The receptor was identified and cloned in the late 1980s and early 1990s during studies of granulocyte colony stimulating factor, a signal that helps the bone marrow make neutrophils. Later, inherited variants in the CSF3R gene were linked to some forms of severe congenital neutropenia, helping explain why certain families had long-standing low neutrophil counts. A major turning point came in 2013, when acquired variants in the CSF3R gene were found to be strongly linked to chronic neutrophilic leukemia. From these first observations, research expanded steadily.